CVS Health (CVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
This article upgrades my rating on CVS Health to 'Buy' as recent negative industry headlines have pressured its valuation. These negatives are fully priced in already, creating a strong GARP (growth at a reasonable price) opportunity. Despite margin pressures, robust EPS growth is projected at double-digit rates. Yet, the forward P/E is just 10x.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
![]() CVS 3 months ago | Other | €0.57 Per Share |
![]() CVS 6 months ago | Other | €0.57 Per Share |
![]() CVS 9 months ago | Other | €0.57 Per Share |
![]() CVS 22 Jul 2024 | Other | €0.57 Per Share |
![]() CVS 19 Apr 2024 | Other | €0.57 Per Share |
5 Aug 2025 (In 1 week) Date | | - Cons. EPS | - EPS |
31 Jul 2025 (In 1 week) Date | | 1.47 Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
![]() CVS 3 months ago | Other | €0.57 Per Share |
![]() CVS 6 months ago | Other | €0.57 Per Share |
![]() CVS 9 months ago | Other | €0.57 Per Share |
![]() CVS 22 Jul 2024 | Other | €0.57 Per Share |
![]() CVS 19 Apr 2024 | Other | €0.57 Per Share |
5 Aug 2025 (In 1 week) Date | | - Cons. EPS | - EPS |
31 Jul 2025 (In 1 week) Date | | 1.47 Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
5 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
Medical - Healthcare Plans Industry | Healthcare Sector | J. David Joyner CEBS CEO | XMUN Exchange | US1266501006 ISIN |
US Country | 219,000 Employees | 22 Jul 2025 Last Dividend | 7 Jun 2005 Last Split | 17 Dec 1984 IPO Date |
CVS Health Corporation is a leading provider of health solutions in the United States, with a comprehensive portfolio that spans across Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness sectors. As an integral part of the healthcare ecosystem, CVS Health offers a broad range of products and services designed to meet the needs of various stakeholders, including employers, individuals, health plans, and governmental entities. Initially named CVS Caremark Corporation, the company underwent a rebranding to CVS Health Corporation in September 2014, emphasizing its broadened focus on health and wellness. Founded in 1996 and headquartered in Woonsocket, Rhode Island, CVS Health has grown into a cornerstone of the American healthcare industry, continually evolving to address the complex challenges of modern healthcare.
CVS Health Corporation offers a diversified array of healthcare products and services, categorized into three main segments: